Cubist Systematic Strategies’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,523
| Closed | -$132K | – | 1601 |
|
|
2024
Q2 | $132K | Sell |
8,523
-233,967
| -96% | -$3.62M | ﹤0.01% | 1140 |
|
|
2024
Q1 | $3.87M | Buy |
242,490
+197,232
| +436% | +$3.14M | 0.02% | 609 |
|
|
2023
Q4 | $761K | Buy |
45,258
+24,452
| +118% | +$411K | ﹤0.01% | 1237 |
|
|
2023
Q3 | $243K | Buy |
+20,806
| New | +$243K | ﹤0.01% | 1468 |
|
|
2023
Q2 | – | Sell |
-189,495
| Closed | -$3.14M | – | 2407 |
|
|
2023
Q1 | $3.14M | Sell |
189,495
-142,919
| -43% | -$2.37M | 0.02% | 862 |
|
|
2022
Q4 | $6.18M | Sell |
332,414
-309,386
| -48% | -$5.75M | 0.04% | 550 |
|
|
2022
Q3 | $8.23M | Buy |
641,800
+287,281
| +81% | +$3.69M | 0.05% | 469 |
|
|
2022
Q2 | $2.49M | Buy |
354,519
+54,924
| +18% | +$385K | 0.02% | 1396 |
|
|
2022
Q1 | $2.48M | Sell |
299,595
-42,167
| -12% | -$350K | 0.02% | 1303 |
|
|
2021
Q4 | $2.31M | Buy |
341,762
+229,567
| +205% | +$1.55M | 0.02% | 1235 |
|
|
2021
Q3 | $595K | Buy |
112,195
+52,140
| +87% | +$277K | 0.01% | 1911 |
|
|
2021
Q2 | $345K | Buy |
60,055
+29,888
| +99% | +$172K | ﹤0.01% | 2247 |
|
|
2021
Q1 | $139K | Sell |
30,167
-1,166
| -4% | -$5.37K | ﹤0.01% | 2579 |
|
|
2020
Q4 | $105K | Sell |
31,333
-8,242
| -21% | -$27.6K | ﹤0.01% | 2401 |
|
|
2020
Q3 | $118K | Sell |
39,575
-212
| -0.5% | -$632 | ﹤0.01% | 2254 |
|
|
2020
Q2 | $184K | Buy |
+39,787
| New | +$184K | ﹤0.01% | 2061 |
|
|
2020
Q1 | – | Sell |
-27,143
| Closed | -$102K | – | 2206 |
|
|
2019
Q4 | $102K | Buy |
+27,143
| New | +$102K | ﹤0.01% | 2185 |
|
|
2019
Q3 | – | Sell |
-81,806
| Closed | -$314K | – | 2250 |
|
|
2019
Q2 | $314K | Buy |
+81,806
| New | +$314K | 0.01% | 1768 |
|
|
2018
Q2 | – | Sell |
-12,835
| Closed | -$31K | – | 1831 |
|
|
2018
Q1 | $31K | Buy |
+12,835
| New | +$31K | ﹤0.01% | 1731 |
|
|
2017
Q2 | – | Sell |
-11,500
| Closed | -$22K | – | 1704 |
|
|
2017
Q1 | $22K | Buy |
+11,500
| New | +$22K | ﹤0.01% | 1539 |
|